4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-035583
Director sold 1,000 shares at $350.01 ($350,005)
- Director acquired 1,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taub Rebecca Director | 2025-07-18 | Option exercise 10b5-1 | +1,000 | $9.45 | $9,450 | 462,044 | D |
| Taub Rebecca Director | 2025-07-18 | Sale 10b5-1 | −1,000 | $350.01 | $350,005 | 461,044 | D |
| Derivatives | |||||||
| Taub Rebecca Director | 2025-07-18 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,000 | 46,463 | D | ||
| Open-market sales · 1,000 sh · avg $350.01 · $350,005 | |||||||
Loading xslF345X05/wk-form4_1753218526.xml…